ACI is excited to return to Washington, D.C. with our one-of-a-kind, interactive forum where stakeholders can gather with peers, discuss challenges, and walk away with tailored strategies for overcoming these challenges.

As our nation continues with attempts to combat the opioid overdose crisis, the regulations and requirements for stakeholders along the entire supply chain continue to evolve at a rapid pace. Recently the DOJ exercised its authority to reduce opioid production and DEA modified its opioid distribution quota rules in an attempt to minimize diversion. Further, state, city, and county litigations continue to escalate, with no end in sight.

Hear from the Experts

Our faculty consisting of current and former DEA officials, DOJ representatives, in-house industry counsel, and outside counsel, will provide an up-to-date analysis of the current regulations, best practices for staying compliant, avoiding DEA investigations, and knowing how to respond when DEA comes knocking at your door.

Hear from the Experts Sample Topics Include:

  • Keeping up with DEA’s evolving suspicious order monitoring and quota requirements
  • DEA inspections and maintaining a compliant facility
  • Tracking state prescription drug monitoring programs
  • County, city, and state opioid enforcement and litigation update

View the Complete Agenda, Speaker Faculty, and More by downloading the Conference Brochure.


Don’t miss this opportunity to benchmark your controlled substances strategies with top industry representatives. Register now and enjoy early bird savings!

Register now

Here’s what some of our attendees had to say about our inaugural event:

“This conference was spot on with the issues we are facing everyday.” Amy D’Anna
Novartis Institutes for Biomedical Research

“It was great to hear from current and former industry leaders and experts from DEA, US AG offices, FDA, etc. Hearing about the current events and upcoming trends/expectations was valuable.” Jaime McDermott
Kroger Health

“As the Director of Compliance for IPC, I was extremely pleased with last year’s speakers and the insight they provided into the latest controlled substance regulations.” Brian Rucker
Independent Pharmacy Cooperative